BioSpace News Archive

X-ray results and pain and function responses highlight the potential of lorecivivint as a first-in-class drug for the treatment of knee osteoarthritis

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will be payable on July 17, 2020, to shareholders of record as of the close of business on June 5, 2020. Cerner intends to pay regular quarterly cash dividends, with future declarations subject to approval by its Board

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has added leading network marketer Daniele Paiola Bellucci to

Kennedy Lewis Investment Management (“Kennedy Lewis”), an opportunistic credit manager, completed a significant commitment to Rapid Micro Biosystems, Inc. (“Rapid Micro”) in the form of a senior secured debt facility as part of the recent $120 million total debt and equity financing.

Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 5,000,000 shares of the Company’s c

The WHO’s COVID-19 webpage will feature a search bar powered by Yext Answers, where site visitors can access official information about COVID-19.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that their COVID-19 vaccine program has reached a milestone with the manufacturing of 33 Ii-Key-SARS-CoV-2 peptides using antigenic epitopes predicted by computational vaccinology algorithms.

Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs).

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”) today announced the closing of its previously announced public offering and concurrent registered direct offering (the “Offerings”) for gross proceeds of approximately $43.7 million, which includes the full exercise of the underwriters’ option to purchase additional shares.

Fitch upgrades the company’s long-term issuer default rating to BB-/Stable Company’s strong operating performance, portfolio management and strong competitive position cited as reasons for the upgrade [22-May-2020] RADNOR, Pa. , May 22, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”), a leading global provider of mission critical